The hypoxia-inflammation link and potential drug targets.
The hypoxia-inflammation link and potential drug targets.
复制标题
DOI:
10.1097/aco.0b013e32834873fd
复制
发表时间:
2011-08
期刊:
影响因子:
--
通讯作者:
Eltzschig HK
中科院分区:
文献类型:
--
作者:
Koeppen M;Eckle T;Eltzschig HK
Hypoxia represents one of the strongest transcriptional stimuli known to us. In most cases, hypoxia-induced changes in gene expression are directed towards adapting tissues to conditions of limited oxygen availability. As a well-known example, physical exercise at high-altitude results in the transcriptional induction of erythropoietin that functions to increase oxygen carrying capacity and red cell volume. Studies of the transcriptional pathway responsible for the induction of erythropoietin during conditions of hypoxia led to the discovery of the transcription factor hypoxia-inducible factor (HIF) that is known today as the key transcription factor for hypoxia adaptation. Surgical patients are frequently at risk for experiencing detrimental effects of hypoxia or ischemia, for example in the context of acute kidney injury, myocardial, intestinal or hepatic ischemia, acute lung injury or during organ transplantation. In the present review we discuss mechanisms of transcriptional adaptation to hypoxia and provide evidence supporting the hypothesis that targeting hypoxia-induced inflammation can represent novel pharmacologic strategies to improve perioperative outcomes. Currently, such strategies are being explored at an experimental level, but we hope that some of these targets can be translated into perioperative patient care within the next decade.